Advanced Biomed Inc. (ADVB)
Advanced Biomed will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $5.00
Shares Offered
25,000,000
Deal Size
$112.50M
Advanced Biomed Statistics
Total Valuation
ADVB has a market cap or net worth of $562.50 million. The enterprise value is $560.27 million.
Market Cap | 562.50M |
Enterprise Value | 560.27M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
ADVB has 125.00 million shares outstanding.
Shares Outstanding | 125.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 235.84 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.13 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 74,236.61 |
Financial Efficiency
Return on equity (ROE) is -199.20% and return on invested capital (ROIC) is -177.05%.
Return on Equity (ROE) | -199.20% |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | -177.05% |
Revenue Per Employee | n/a |
Profits Per Employee | -$125,028 |
Employee Count | 38 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (30 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -4.75M |
Pretax Income | -4.75M |
Net Income | -4.75M |
EBITDA | -4.44M |
EBIT | -4.75M |
Earnings Per Share (EPS) | -$0.04 |
Balance Sheet
The company has $2.53 million in cash and $299,219 in debt, giving a net cash position of $2.23 million or $0.02 per share.
Cash & Cash Equivalents | 2.53M |
Total Debt | 299,219 |
Net Cash | 2.23M |
Net Cash Per Share | $0.02 |
Equity / Book Value | 2.39M |
Book Value Per Share | 0.02 |
Working Capital | 1.03M |
Cash Flow
In the last 12 months, operating cash flow was -$4.67 million and capital expenditures -$709,910, giving a free cash flow of -$5.38 million.
Operating Cash Flow | -4.67M |
Capital Expenditures | -709,910 |
Free Cash Flow | -5.38M |
FCF Per Share | -$0.04 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ADVB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -0.84% |
FCF Yield | -0.96% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |